Gene · 7306
Papers3,635
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 3,635
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Signaling of Tumor-Derived sEV Impacts Melanoma Progression. | Int J Mol Sci | 2020 | 32709086 | PubTator, text mining | PubMed |
| Emerging Strategies to Protect the Skin from Ultraviolet Rays Using Plant-Derived Materials. | Antioxidants (Basel) | 2020 | 32708455 | PubTator, text mining | PubMed |
| Thymocid®, a Standardized Black Cumin (Nigella sativa) Seed Extract, Modulates Collagen Cross-Linking, Collagenase and Elastase Activities, and Melanogenesis in Murine B16F10 Melanoma Cells. | Nutrients | 2020 | 32707654 | PubTator, text mining | PubMed |
| An in vitro model of chronic wounding and its implication for age-related macular degeneration. | PLoS One | 2020 | 32701996 | PubTator, text mining | PubMed |
| Melatonin Induces Melanogenesis in Human SK-MEL-1 Melanoma Cells Involving Glycogen Synthase Kinase-3 and Reactive Oxygen Species. | Int J Mol Sci | 2020 | 32674468 | PubTator, text mining | PubMed |
| Rab27a co-ordinates actin-dependent transport by controlling organelle-associated motors and track assembly proteins. | Nat Commun | 2020 | 32661310 | PubTator, text mining | PubMed |
Sulforaphane controls the release of paracrine factors by keratinocytes and thus mitigates particulate matter-induced premature skin aging by suppressing melanogenesis and maintaining collagen homeostasis. | Phytomedicine | 2020 | 32659677 | PubTator, text mining | PubMed |
| BRAF Inhibitors: Molecular Targeting and Immunomodulatory Actions. | Cancers (Basel) | 2020 | 32645969 | PubTator, text mining | PubMed |
| Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma. | Mol Ther Oncolytics | 2020 | 32637583 | PubTator, text mining | PubMed |
| Comorbidity of sickle cell trait and albinism: a cross-sectional survey in the Democratic Republic of the Congo. | Pan Afr Med J | 2020 | 32637025 | PubTator, text mining | PubMed |
| The plasma peptides of sepsis. | Clin Proteomics | 2020 | 32636717 | PubTator, text mining | PubMed |
| Using the PubAnnotation ecosystem to perform agile text mining on Genomics & Informatics: a tutorial review. | Genomics Inform | 2020 | 32634867 | PubTator, text mining | PubMed |
| Laminin-511-E8 promotes efficient in vitro expansion of human limbal melanocytes. | Sci Rep | 2020 | 32632213 | PubTator, text mining | PubMed |
| Cell-Mediated Release of Nanoparticles as a Preferential Option for Future Treatment of Melanoma. | Cancers (Basel) | 2020 | 32630815 | PubTator, text mining | PubMed |
| Syntenin regulates melanogenesis via the p38 MAPK pathway. | Mol Med Rep | 2020 | 32626944 | PubTator, text mining | PubMed |
| Synthesis and Biological Evaluation of the Anti-Melanogenesis Effect of Coumaric and Caffeic Acid-Conjugated Peptides in Human Melanocytes. | Front Pharmacol | 2020 | 32625101 | PubTator, text mining | PubMed |
| [Spectrum of pathological genetic variants among 405 Chinese pedigrees affected with oculocutaneous albinism]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2020 | 32619251 | PubTator, text mining | PubMed |
| Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers. | Nanomaterials (Basel) | 2020 | 32610601 | PubTator, text mining | PubMed |
| Targeted Therapy in Melanoma and Mechanisms of Resistance. | Int J Mol Sci | 2020 | 32605090 | PubTator, text mining | PubMed |
| Recent advances in understanding the molecular basis of melanogenesis in melanocytes. | F1000Res | 2020 | 32595944 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7306/papers?page=61